paclitaxel has been researched along with Idiopathic Inflammatory Myopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barrios-Anderson, A; Radhakrishnan, R; Shimanovsky, A; Yu, E | 1 |
DiCaudo, DJ; Farhey, Y; Griffing, WL; Martorano, LM; Trotter, SC; Winkelmann, JC; Winkelmann, RR; Yiannias, JA | 1 |
2 review(s) available for paclitaxel and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Paraspinal radiation recall myositis after gemcitabine for pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Myositis; Paclitaxel; Pancreatic Neoplasms | 2021 |
Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Esophageal Motility Disorders; Female; Humans; Immunohistochemistry; Middle Aged; Myositis; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prognosis; Raynaud Disease; Risk Assessment; Scleroderma, Systemic; Treatment Outcome | 2016 |